The largest database of trusted experimental protocols

Akta pure protein purification system

Manufactured by Cytiva

The AKTA pure is a protein purification system designed to automate the process of purifying proteins from complex samples. It is equipped with advanced chromatography functionalities to enable efficient separation, fractionation, and collection of target proteins. The system is user-friendly and provides reliable and reproducible results, making it a versatile tool for researchers and scientists in the field of protein research and development.

Automatically generated - may contain errors

4 protocols using akta pure protein purification system

1

Oligomeric states of 3CLpro mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
The oligomeric states of the 3CLpro mutants were analyzed by aSEC on a Superdex 200 Increase 10/300 GL using an AKTA pure protein purification system (Cytiva Life Sciences). The column was pre-equilibrated with 20 mM Hepes (pH 7.5), and 50 μl of protein sample with a concentration of >7 mg/ml was injected at a flow rate of 0.75 ml/min and temperature of 4 °C. The 4 °C temperature is important to maintain 3CLpro in the dimeric state as was shown previously for 3CLpro SARS-CoV that room temperature induces an equilibrium between the monomeric and dimeric states of the enzyme (22 ). Each variant was analyzed three times to confirm the reliability of the data. The absorbance signal was normalized to the maximum value recorded at 280 nm for the different mutants of 3CLpro. Molecular weight standards were used to calibrate the column using a low molecular mass gel filtration kit (Cytiva Life Sciences/Biacore) with carbonic anhydrase (29.6 kDa) and ribokinase (70 kDa) as marker proteins mimicking the monomeric and dimeric forms of the WT enzyme, which have molecular weights of 34.5 and 69 kDa, respectively.
+ Open protocol
+ Expand
2

Recombinant Antibody Generation from Hybridoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted and amplified from cloned hybridoma cell pellets based on a modified 5′ Rapid Amplification of cDNA Ends (5′ RACE) as previously described (Turchaninova et al., 2016 (link)). Prepped amplicon libraries were then sequenced using a Sequel Platform (Pacific Biosciences). Isotype and subclass was determined through sequence of constant regions Sequence analysis to determine the antibody gene segments, complementarity determining regions (CDRs), and % mutation from germline was performed using ImMunoGeneTics (IMGT) V-QUEST tool (Giudicelli et al., 2011 ). cDNAs encoding antibody genes for heavy and light chains were cloned into a vector expressing full-length IgG1 (Twist Biosciences). ExpiCHO cells were transiently transfected with plasmids encoding full-length IgG cDNAs. Supernatant was harvested from ExpiCHO cultures and filtered with 0.45-μm pore size filter flasks. HiTrap MabSelectSure columns (Cytiva) then were used to affinity purify mAbs from ExpiCHO supernatant using an AKTA pure protein purification system (Cytiva). Recombinant antibodies were used in animal studies described below.
+ Open protocol
+ Expand
3

Recombinant Antibody Generation from Hybridoma

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was extracted and amplified from cloned hybridoma cell pellets based on a modified 5′ Rapid Amplification of cDNA Ends (5′ RACE) as previously described (Turchaninova et al., 2016 (link)). Prepped amplicon libraries were then sequenced using a Sequel Platform (Pacific Biosciences). Isotype and subclass was determined through sequence of constant regions Sequence analysis to determine the antibody gene segments, complementarity determining regions (CDRs), and % mutation from germline was performed using ImMunoGeneTics (IMGT) V-QUEST tool (Giudicelli et al., 2011 ). cDNAs encoding antibody genes for heavy and light chains were cloned into a vector expressing full-length IgG1 (Twist Biosciences). ExpiCHO cells were transiently transfected with plasmids encoding full-length IgG cDNAs. Supernatant was harvested from ExpiCHO cultures and filtered with 0.45-μm pore size filter flasks. HiTrap MabSelectSure columns (Cytiva) then were used to affinity purify mAbs from ExpiCHO supernatant using an AKTA pure protein purification system (Cytiva). Recombinant antibodies were used in animal studies described below.
+ Open protocol
+ Expand
4

Expression and Purification of VP40 Mutants

Check if the same lab product or an alternative is used in the 5 most similar protocols
VP40 mutations were generated by Gene Universal (Newark, DE) and confirmed by DNA sequencing. VP40 was expressed in RosettaTM BL21DE3 cells and purified as previously described (Johnson et al., 2021 (link); Narkhede et al., 2023 (link)) using affinity and size exclusion chromatography. Briefly, cell pellets were lysed for 30 min on ice in lysis buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, pH 8.0) containing 20 μg/mL lysozyme, 1 μg/mL ribonuclease A, 30 μM PMSF, and 1x HALT protease inhibitor cocktail. The lysate was then subjected to sonication (10 sec on, 59 sec off for 10 times on ice). The lysate was cleared by centrifugation at 50,000 x g for 30 min. The cleared lysate was filtered and incubated with Ni‐NTA beads for 20 min at 4°C in an orbital shaker. The beads were then washed with wash buffer (50 mM NaH2PO4, 300 mM NaCl, 30 mM imidazole, pH 8.0) and VP40 protein was eluted with elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 8.0). Size exclusion chromatography (HiLoad 16/600 Superdex 200 pg column) was performed on the eluted protein fractions by running in storage buffer (10 mM HEPES, pH 8.0 containing 150 mM NaCl)) using an AKTA PURE Protein Purification System (Cytiva, Marlborough, MA) to separate and detect VP40 dimer and octamer fractions for WT VP40 and respective mutations.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!